Internal Medicine, Nephrology · Milwaukee, WI
NPI
1376786384
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
945 N 12th St
Milwaukee, WI, 53233
Phone (414) 219-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
887 services
Medicare patients, 2024
202
Average age 73
Drug cost, 2024
$654K
6,646 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lamya Boujelbane was code 99232 (hospital e&m - subsequent), 332 times for 57 patients. In total Lamya Boujelbane billed 887 services in 13 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 332 | 57 | $57.38 | $19K |
| 99233 Hospital E&M - Subsequent | Facility | 230 | 40 | $86.38 | $20K |
| 99214 Office E&M - Established | Facility | 95 | 61 | $65.82 | $6,253 |
| 99214 Office E&M - Established | Office | 92 | 59 | $78.38 | $7,211 |
| 99223 Hospital E&M - Initial | Facility | 78 | 53 | $127.60 | $9,953 |
| 99204 Office E&M - New | Office | 19 | 19 | $106.13 | $2,016 |
| 99204 Office E&M - New | Facility | 18 | 18 | $68.03 | $1,224 |
By year: 2022 $86K for 1,158 services; 2023 $52K for 660 services; 2024 $67K for 887 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lamya Boujelbane prescribed most often to Medicare patients was Losartan Potassium, with 746 prescriptions and refills. In total Lamya Boujelbane wrote 6,646 Medicare prescriptions that cost $654K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 746 | 1,590 | 214 | $4,873 |
| Allopurinol Generic | 543 | 1,172 | 155 | $3,902 |
| Spironolactone Generic | 389 | 851 | 106 | $2,934 |
| Jardiance Empagliflozin | 365 | 571 | 102 | $334K |
| Amlodipine Besylate Generic | 331 | 720 | 113 | $2,115 |
| Indapamide Generic | 297 | 662 | 86 | $4,714 |
| Bumetanide Generic | 257 | 494 | 83 | $7,254 |
| Calcitriol Generic | 253 | 471 | 68 | $3,694 |
| Furosemide Generic | 252 | 447 | 72 | $850 |
| Potassium Chloride Generic | 230 | 374 | 68 | $4,611 |
| Lisinopril Generic | 214 | 496 | 68 | $1,488 |
| Carvedilol Generic | 196 | 380 | 52 | $1,657 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 171 | 414 | 68 | $1,207 |
| Atorvastatin Calcium Generic | 165 | 365 | 45 | $1,831 |
| Lokelma Sodium Zirconium Cyclosilicate | 157 | 235 | 44 | $101K |
Brand drugs: 777 claims; generic drugs: 5,869 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Lamya Boujelbane were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.